(Q46785915)

25 December 2017

title

Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice (English)

1 reference

25 December 2017

0 references

1 reference

H K Caldwell

1

1 reference

25 December 2017

S L Stephens

series ordinal

2

1 reference

25 December 2017

W S Young

series ordinal

3

1 reference

25 December 2017

language of work or name

English

0 references

publication date

29 January 2008

1 reference

25 December 2017

published in

Molecular Psychiatry

1 reference

25 December 2017

volume

14

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

190-196

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.mp.4002150

exact match

0 references

cites work

Gating and habituation of the startle reflex in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Sensorimotor gating and habituation evoked by electro-cutaneous stimulation in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Startle gating deficits occur across prepulse intensities in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Abnormalities of the blink reflex in Gilles de la Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an "fMRI-friendly" startle paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

The acoustic startle response in rats--circuits mediating evocation, inhibition and potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Cross-species studies of sensorimotor gating of the startle reflex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Dendritic release of vasopressin and oxytocin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Magnocellular dendrites: prototypic receiver/transmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Deficiency in mouse oxytocin prevents milk ejection, but not fertility or parturition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

The Effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Phencyclidine-induced psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

PCP: from pharmacology to modelling schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Modulating sensory gating in healthy volunteers: the effects of ketamine and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Clinical and sensorimotor gating effects of ketamine in normals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Low dose ketamine increases prepulse inhibition in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Prestimulus effects on human startle reflex in normals and schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Phencyclidine (PCP)-induced deficits of prepulse inhibition in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

The comparative distribution of forebrain receptors for neurohypophyseal peptides in monogamous and polygamous mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Gonadal steroids have paradoxical effects on brain oxytocin receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Mapping oxytocin receptor gene expression in the mouse brain and mammary gland using an oxytocin receptor–LacZ reporter mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Distribution of glutamate receptors of the NMDA subtype in brains of heterozygous and homozygous weaver mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

In vivo labeling of phencyclidine (PCP) receptors with 3H-TCP in the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Glutamatergic input governs periodicity and synchronization of bursting activity in oxytocin neurons in hypothalamic organotypic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Glutamate, the dominant excitatory transmitter in neuroendocrine regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Interaction between magnocellular neurons and cells of the perinuclear zone involves NMDA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Burst firing of oxytocin neurons in male rat hypothalamic slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Vasopressin and oxytocin decrease excitatory amino acid release in adult rat supraoptic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Oxytocin enhances presynaptic and postsynaptic glutamatergic transmission between rat olfactory bulb neurones in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Effects of sigma(1) receptor ligand, MS-377 on apomorphine- or phencyclidine-induced disruption of prepulse inhibition of acoustic startle in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

The effects of atypical antipsychotic medications on psychosocial outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Social amnesia in mice lacking the oxytocin gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Reduced aggressive behaviour in mice with targeted disruption of the oxytocin gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Female Oxytocin-Deficient Mice Display Enhanced Anxiety-Related Behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

7 January 2021

A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

7 January 2021

Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

7 January 2021

Is Oxytocin an Anti-Schizophrenic Hormone?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

7 January 2021

The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

7 January 2021

The effect of 1-arylcylohexylamine (sernyl) on twelve normal volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

7 January 2021

Excitatory amino acid antagonists inhibit synaptic responses in the guinea pig hypothalamic paraventricular nucleus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

7 January 2021

Modulation of synaptic transmission by oxytocin and vasopressin in the supraoptic nucleus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002150

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4002150

1 reference

25 December 2017

PubMed ID

18227836

1 reference

25 December 2017